Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system

Diabetes Technology and Therapeutics

Volumn 16, Issue 6, 2014, Pages 348-357

  Harvey, Rebecca A ^a,b   Dassau, Eyal ^a,b,c   Bevier, Wendy C ^a   Seborg, Dale E ^a,b   Jovanovič, Lois ^a,b   Doyle, Francis J ^a,b,c   Zisser, Howard C ^a,b  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^b University of California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LACTIC ACID; SHORT ACTING INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; ALGORITHM; ANALYZER; ARTICLE; ARTIFICIAL PANCREAS; AUTOMATION; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE DURATION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH MONITORING SYSTEM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEAL; MONITORING; PRIORITY JOURNAL; BLOOD; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS, TYPE 1; INSULIN INFUSION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; PREDICTIVE VALUE;

ADULT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MEALS; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PANCREAS, ARTIFICIAL; PREDICTIVE VALUE OF TESTS;

EID: 84900832698     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0231     Document Type: Article

References (37)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
2. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-1298.
3. Bellazzi R, Arcelloni M, Bensa G, Blankenfeld H, Brugues E, Carson E, Cobelli C, Cramp D, D'Annunzio G, De Cata P, De Leiva A, Deutsch T, Fratino P, Gazzaruso C, Garcia A, Gergely T, Gomez E, Harvey F, Ferrari P, Hernando E, Boulos MK, Larizza C, Ludekke H, Maran A, Nucci G, Pennati C, Ramat S, Roudsari A, Rigla M, Stefanelli M: Design, methods, and evaluation directions of a multiaccess service for the management of diabetes mellitus patients. Diabetes Technol Ther 2003;5:621-629.
4. American Diabetes Association: Standards of medical care in diabetes-2012. Diabetes Care 2012;35(Suppl 1): S11-S63.
5. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER: A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2(27):27ra27.
6. El-Khatib FH, Jiang J, Damiano ER: A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine. J Diabetes Sci Technol 2009;3:789-803.
7. Castle JR, Engle JM, Youssef JE, Massoud RG, Yuen KC, Kagan R, Ward WK: Novel use of glucagon in a closedloop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010;33:1282-1287.
8. Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R: Glucose-responsive insulin and glucagon delivery (dualhormone artificial pancreas) in adults with type 1 diabetes: A randomized crossover controlled trial. CMAJ 2013;185:297-305.
9. Steil GM, Palerm CC, Kurtz N, Voskanyan G, Roy A, Paz S, Kandeel FR: The effect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab 2011;96: 1402-1408.
10. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M: MDLogic artificial pancreas system: A pilot study in adults with type 1 diabetes. Diabetes Care 2010;33:1072-1076.
11. Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A: Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technol 2009;3:1014-1021.
12. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011;342:d1855.
13. Patek SD, Magni L, Dassau E, Karvetski C, Toffanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle III FJ, Cobelli C, Kovatchev BP; International Artificial Pancreas (iAP) Study Group: Modular closed-loop control of diabetes. IEEE Trans Biomed Eng 2012;59:2986-2999.
14. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle III FJ, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237.
15. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B: Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: The Virginia experience. J Diabetes Sci Technol 2009;3:1031-1038.
16. Dassau E, Zisser H, Harvey RA, Percival MW, Grosman B, Bevier W, Atlas E, Miller S, Nimri R, Jovanovic L, Doyle III FJ: Clinical evaluation of a personalized artificial pancreas. Diabetes Care 2013;36:801-809.
17. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB: Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: A phase 2 randomised crossover trial. Lancet 2010;375:743-751.
18. Cobelli C, Renard E, Kovatchev BP, Keith-Hynes P, Ben Brahim N, Place J, Del Favero S, Breton M, Farret A, Bruttomesso D, Dassau E, Zisser H, Doyle III FJ, Patek SD, Avogaro A: Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care 2012;35:e65-e67.
19. Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM: Closed-loop insulin therapy improves glycemic control in children aged
20. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ Apr 2011;342:d1855.
21. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939.
22. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF: Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55:3344-3350.
23. Mauseth R, Wang Y, Dassau E, Kircher R Jr, Matheson D, Zisser H, Jovanovic L, Doyle III FJ: Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor. J Diabetes Sci Technol 2010;4:913-922.
24. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833.
25. Parker RS, Doyle III FJ, Harting JE, Peppas NA: Model predictive control for infusion pump insulin delivery. In: Proceedings of the 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Vol. 5: Bridging Disciplines for Biomedicine. Piscataway, NJ: IEEE, 1996:1822-1823.
26. Parker RS, Doyle III FJ, Peppas NA: A model-based algorithm for blood glucose control in type 1 diabetic patients. IEEE Trans Biomed Eng 1999;46:148-157.
27. Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A: Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol 2010;4:1374-1381.
28. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovic L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL: American Association of Clinical Endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract 2011;17(Suppl 2):1-53.
29. Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle III FJ: Zone model predictive control: A strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol 2010;4:961-975.
30. van Heusden K, Dassau E, Zisser HC, Seborg DE, Doyle III FJ: Control-relevant models for glucose control using a priori patient characteristics. IEEE Trans Biomed Eng 2012;59:1839-1849.
31. Mackowiak L, Finan DA, McCann TW Jr, Venugopalan R, Zisser H, Anhalt H: Feasibility study assessing hypoglycemiahyperglycemia minimizer (HHM) system in patients with type 1 diabetes (T1DM) in a clinical research center [abstract]. Diabetes 2012;61(Suppl 1):A233.
32. Venugopalan R, Finan DA, McCann TW Jr, Mackowiak L, Dassau E, Patek SD, Anhalt H: Performance metrics of a hypoglycemia-hyperglycemia minimizer (HHM) system in a closed-loop feasibility study [abstract]. Diabetes 2012; 61(Suppl 1):A235.
33. Zisser CH, Dassau E, Bevier W, Harvey R, Jovanovič L, Doyle III FJ: Clinical evaluation of a fully-automated artificial pancreas using zone-model predictive control with health monitoring system [abstract]. Diabetes 2012; 61(Suppl 1):LB8.
34. Harvey RA, Dassau E, Zisser H, Seborg DE, Jovanovič L, Doyle III FJ: Design of the health monitoring system for the artificial pancreas: low glucose prediction module. J Diabetes Sci Technol 2012;6:1345-1354.
35. Dassau E, Zisser H, Palerm CC, Buckingham BA, Jovanovič L, Doyle III FJ: Modular artificial b-cell system: A prototype for clinical research. J Diabetes Sci Technol 2008;2:863-872.
36. Karvonen MJ, Kentala E, Mustala O: The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn 1957;35:307-315.
37. Clarke WL: The original Clarke Error Grid Analysis (EGA). Diabetes Technol Ther 2005;7:776-779.